Published in Antimicrob Agents Chemother on August 16, 2010
Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Clin Infect Dis (2011) 2.15
Influenza neuraminidase. Influenza Other Respir Viruses (2011) 1.31
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis (2011) 1.31
Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother (2011) 1.16
Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection. Antimicrob Agents Chemother (2011) 1.12
Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection. Antimicrob Agents Chemother (2011) 1.02
Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques. Antimicrob Agents Chemother (2011) 0.91
Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice. Antimicrob Agents Chemother (2013) 0.86
Clinical effectiveness of peramivir in comparison with other neuraminidase inhibitors in pediatric influenza patients. Int J Pediatr (2012) 0.85
Recent advances in the diagnosis and treatment of influenza pneumonia. Curr Infect Dis Rep (2012) 0.81
Safety and efficacy of peramivir for influenza treatment. Drug Des Devel Ther (2014) 0.79
Peramivir injection in the treatment of acute influenza: a review of the literature. Infect Drug Resist (2016) 0.79
Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections. Front Microbiol (2016) 0.78
Population Pharmacokinetics of Peramivir in Healthy Volunteers and Influenza Patients. Antimicrob Agents Chemother (2015) 0.77
Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques. Antimicrob Agents Chemother (2014) 0.77
Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in Japan. PLoS One (2015) 0.76
In-silico structural analysis of the influenza A subtype H7N9 neuraminidase and molecular docking with different neuraminidase inhibitors. Virusdisease (2015) 0.75
Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis. Yonsei Med J (2017) 0.75
Japanese Surveillance Systems and Treatment for Influenza. Curr Treat Options Infect Dis (2016) 0.75
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Monoclonal Antibody, MHAB5553A, in Healthy Volunteers. Antimicrob Agents Chemother (2017) 0.75
Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Challenge Model: A Phase 2 Randomized Trial. Antimicrob Agents Chemother (2017) 0.75
Efficacy and Safety of Intravenous Peramivir Compared With Oseltamivir in High-Risk Patients Infected With Influenza A and B Viruses: A Multicenter Randomized Controlled Study. Open Forum Infect Dis (2017) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 10.27
Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA (2009) 10.13
Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal Biochem (1979) 7.09
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med (1997) 6.23
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet (2005) 5.70
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis (2007) 5.39
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis (2007) 5.21
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet (2000) 5.03
Sample sizes based on the log-rank statistic in complex clinical trials. Biometrics (1988) 2.97
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother (2001) 2.46
Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis (2009) 2.17
The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med (2009) 1.86
H1N1 pneumonitis treated with intravenous zanamivir. Lancet (2009) 1.73
Anti-influenza virus activity of peramivir in mice with single intramuscular injection. Antiviral Res (2005) 1.42
Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J (2004) 1.37
Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J Immunol (2009) 1.27
Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology (2008) 1.23
Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza. PLoS One (2008) 1.21
Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus. Antivir Ther (2007) 0.99
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62
Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70
Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog (2009) 2.29
Polymorphisms and the differential antiviral activity of the chicken Mx gene. Genome Res (2002) 2.18
Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine (2003) 1.78
Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One (2010) 1.64
Replication and transmission of influenza viruses in Japanese quail. Virology (2003) 1.64
Assembly and budding of Ebolavirus. PLoS Pathog (2006) 1.62
Bovine kobuviruses from cattle with diarrhea. Emerg Infect Dis (2008) 1.61
Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity. Am J Respir Crit Care Med (2012) 1.55
Characterization of H5N1 highly pathogenic avian influenza virus strains isolated from migratory waterfowl in Mongolia on the way back from the southern Asia to their northern territory. Virology (2010) 1.48
Neurotropism of the 1997 Hong Kong H5N1 influenza virus in mice. Vet Microbiol (2003) 1.47
Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. Kidney Int (2004) 1.46
Interstitial deletion of 13q14.13-q32.3 presenting with Arima syndrome and bilateral retinoblastoma. Brain Dev (2010) 1.45
Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem (2010) 1.43
Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. Brain Dev (2008) 1.41
Hepatoblastoma in a patient with sotos syndrome. J Pediatr (2009) 1.40
Resistance to influenza A virus infection in transformed cell lines expressing an anti-PB2 monoclonal antibody. Vet J (2013) 1.39
Congenital infection-like syndrome with intracranial calcification. Brain Dev (2010) 1.39
Generation of velogenic Newcastle disease viruses from a nonpathogenic waterfowl isolate by passaging in chickens. Virology (2002) 1.37
The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors. Glycobiology (2007) 1.37
PB2 protein of a highly pathogenic avian influenza virus strain A/chicken/Yamaguchi/7/2004 (H5N1) determines its replication potential in pigs. J Virol (2008) 1.36
Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles. J Virol (2002) 1.30
Interregional transmission of the internal protein genes of H2 influenza virus in migratory ducks from North America to Eurasia. Virus Genes (2004) 1.28
The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of action. FEMS Microbiol Lett (2004) 1.28
Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev (2011) 1.26
Molecular characterization of the hemagglutinin and neuraminidase genes of H5N1 influenza A viruses isolated from poultry in Vietnam from 2004 to 2005. J Vet Med Sci (2006) 1.23
A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. Proc Natl Acad Sci U S A (2002) 1.23
Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin. Virology (2008) 1.23
Detection, genetic characterization, and quantification of norovirus RNA from sera of children with gastroenteritis. J Clin Virol (2009) 1.23
Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung. Clin Cancer Res (2011) 1.22
Serological evidence of transmission of human influenza A and B viruses to Caspian seals (Phoca caspica). Microbiol Immunol (2002) 1.21
Acute necrotizing encephalopathy of childhood in non-Asian patients: report of three cases and literature review. J Child Neurol (2006) 1.21
A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2002) 1.20
Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis (2005) 1.19
H9N2 influenza viruses prevalent in poultry in China are phylogenetically distinct from A/quail/Hong Kong/G1/97 presumed to be the donor of the internal protein genes of the H5N1 Hong Kong/97 virus. Avian Pathol (2003) 1.19
Development of vaccine strains of H5 and H7 influenza viruses. Jpn J Vet Res (2008) 1.18
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat Commun (2012) 1.16
Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother (2011) 1.16
Genetic diversity of noroviruses and sapoviruses in children hospitalized with acute gastroenteritis in Chiang Mai, Thailand. J Med Virol (2007) 1.15
Isolation and characterization of potentially pathogenic H5N2 influenza virus from a chicken in Taiwan in 2008. Avian Dis (2010) 1.13
Reintroduction of H5N1 highly pathogenic avian influenza virus by migratory water birds, causing poultry outbreaks in the 2010-2011 winter season in Japan. J Gen Virol (2011) 1.13
Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection. Antimicrob Agents Chemother (2011) 1.12
In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci. Antimicrob Agents Chemother (2003) 1.11
Seroepidemiological evidence of avian H4, H5, and H9 influenza A virus transmission to pigs in southeastern China. Vet Microbiol (2002) 1.09
Subcutaneous hematoma due to frequent insulin injections in a single site. Intern Med (2004) 1.08
Nucleocapsid-like structures of Ebola virus reconstructed using electron tomography. J Vet Med Sci (2005) 1.06
In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models. Antimicrob Agents Chemother (2003) 1.05
Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung. J Pathol (2003) 1.05
Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol (2008) 1.04
Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope. J Virol (2007) 1.04
Molecular epidemiology of adenovirus infection among infants and children with acute gastroenteritis in Dhaka City, Bangladesh. Infect Genet Evol (2009) 1.03
Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy. Am J Respir Crit Care Med (2011) 1.02
Pathogenicity of H5N1 influenza A viruses isolated in Vietnam between late 2003 and 2005. J Vet Med Sci (2006) 1.01
H2N5 influenza virus isolates from terns in Australia: genetic reassortants between those of the Eurasian and American lineages. Virus Genes (2008) 0.99
Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis. Cancer Res (2012) 0.99
Antigenic, genetic, and pathogenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from dead whooper swans (Cygnus cygnus) found in northern Japan in 2008. Virus Genes (2010) 0.99
Use of multilocus variable-number tandem repeat analysis in molecular subtyping of Salmonella enterica serovar Typhi isolates. J Med Microbiol (2011) 0.98
Safe and successful treatment with erlotinib after gefitinib-induced hepatotoxicity: difference in metabolism as a possible mechanism. J Clin Oncol (2011) 0.98
Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer. Cancer Res (2010) 0.97
Identification of new genetic subtypes of bovine viral diarrhea virus genotype 1 isolated in Japan. Virus Genes (2008) 0.97
Adaptation of a duck influenza A virus in quail. J Virol (2011) 0.96
Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens. Microbiol Immunol (2006) 0.95
p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transplant (2002) 0.95
Ecology and epidemiology of anthrax in cattle and humans in Zambia. Jpn J Vet Res (2006) 0.95
EYA4, deleted in a case with middle interhemispheric variant of holoprosencephaly, interacts with SIX3 both physically and functionally. Hum Mutat (2009) 0.95
Insertion of cellular sequence and RNA recombination in the structural protein coding region of cytopathogenic bovine viral diarrhoea virus. J Gen Virol (2003) 0.95
Rapid detection of avian influenza virus a and subtype H5N1 by single step multiplex reverse transcription-polymerase chain reaction. Virus Genes (2006) 0.94
Human bocavirus infection in children with acute gastroenteritis in Japan and Thailand. J Med Virol (2011) 0.94
The genetic and antigenic diversity of avian influenza viruses isolated from domestic ducks, muscovy ducks, and chickens in northern and southern Vietnam, 2010-2012. Virus Genes (2013) 0.94
Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata. Mod Pathol (2005) 0.94
Potency of an inactivated influenza vaccine prepared from a non-pathogenic H5N1 virus against a challenge with antigenically drifted highly pathogenic avian influenza viruses in chickens. Vet Microbiol (2013) 0.94
Apoptosis and microglial activation in influenza encephalopathy. Acta Neuropathol (2002) 0.93
Changing pattern of rotavirus G genotype distribution in Chiang Mai, Thailand from 2002 to 2004: decline of G9 and reemergence of G1 and G2. J Med Virol (2007) 0.93
Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam. PLoS One (2013) 0.93
Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth. Am J Respir Cell Mol Biol (2003) 0.92
Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer. Cancer Sci (2011) 0.92
Genetic comparisons between lentogenic Newcastle disease virus isolated from waterfowl and velogenic variants. Virus Genes (2009) 0.92
Diversity of human parechoviruses isolated from stool samples collected from Thai children with acute gastroenteritis. J Clin Microbiol (2009) 0.91
Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferation. Acta Neuropathol (2007) 0.91
Antigenic structure of the hemagglutinin of H9N2 influenza viruses. Arch Virol (2008) 0.91
Antigenic and genetic analysis of H5 influenza viruses isolated from water birds for the purpose of vaccine use. Arch Virol (2008) 0.91
Experimental dual infection of pigs with an H1N1 swine influenza virus (A/Sw/Hok/2/81) and Mycoplasma hyopneumoniae. Vet Microbiol (2004) 0.91
Four-year study of viruses that cause diarrhea in Japanese pediatric outpatients. J Med Virol (2015) 0.91
Characterization of H3N6 avian influenza virus isolated from a wild white pelican in Zambia. Arch Virol (2009) 0.91
Type-I interferon is critical for FasL expression on lung cells to determine the severity of influenza. PLoS One (2013) 0.91
Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice. Vaccine (2002) 0.90
A low pathogenic H5N2 influenza virus isolated in Taiwan acquired high pathogenicity by consecutive passages in chickens. J Vet Med Sci (2011) 0.90
Gnarled-trunk evolutionary model of influenza A virus hemagglutinin. PLoS One (2011) 0.90